Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab
Clinical trial NCT02600169 · COMPLETED
Trial details
- NCT number
- NCT02600169
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-01
- Primary completion
- 2019-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.